UPDATE 1-AstraZeneca?s $4 bln Acerta deal endorsed by orphan drug status
 

UPDATE 1-AstraZeneca?s $4 bln Acerta deal endorsed by orphan drug status
LONDON, Feb 25 (Reuters) - AstraZeneca's bold moveto buy 55 percent of privately held biotech firm Acerta Pharmafor $4 billion in December has been vindicated, at least inpart, by the award of...http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut..._8:V_sGLiPBpWU http://feeds.feedburner.com/~ff/reut..._8:F7zBnMyn0Lo
http://feeds.feedburner.com/~r/reute...~4/vPqqcKw_REY